Laser zaps painful lumps in early HS trial

NCT ID NCT07155239

Recruiting now Symptom relief Sponsor: Wynn Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This pilot study tests a 1726-nm laser (AviClear) to reduce painful lumps and abscesses in hidradenitis suppurativa (HS), a chronic skin condition. Thirty adults with mild-to-moderate HS will have one side of their body treated with the laser and the other side with a sham procedure. The goal is to see if the laser safely lowers inflammation and improves symptoms over 24 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 1726-nm diode laser (AviClear)
What this could lead to: If it works, this could point toward a non-invasive laser treatment to ease painful skin lumps in early-stage hidradenitis suppurativa.
What could go wrong: This is a very early Phase 1 pilot trial with only 30 people. The laser may not reduce symptoms better than no treatment, and results may not apply to all skin types or disease stages.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hidradenitis suppurativa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIDRADENITIS SUPPURATIVA (HS)

Contacts and locations

Locations

Wynn Medical Center Rheumatology/Dermatology
RECRUITING

Rosemead, California, 91770, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.